MPAM
ORGO icon

Monarch Partners Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Monarch Partners Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$817K Buy
303,681
+2,201
+0.7% +$6.42K 0.24% 128
2022
Q3 		$977K Hold
301,480
– – 0.29% 124
2022
Q2 		$1.47M Buy
+301,480
New +$1.86M 0.41% 117

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Monarch Partners Asset Management's ORGO Position: Q4 2022 in Review

Monarch Partners Asset Management increased its Organogenesis Holdings (ORGO) stake by 0.73% in Q4 2022, buying an estimated $6.42K and bringing the position to 303,681 shares worth $817K. The position accounts for 0.24% of the portfolio, ranked #128.

Monarch Partners Asset Management first reported a position in ORGO in Q2 2022 and has held it in 3 quarters since. The position peaked at $1.47M in Q2 2022. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Monarch Partners Asset Management held 303,681 shares of Organogenesis Holdings worth $817K as of Q4 2022.
  • Monarch Partners Asset Management bought 2,201 Organogenesis Holdings shares in Q4 2022, an estimated $6.42K.
  • Organogenesis Holdings made up 0.24% of Monarch Partners Asset Management's portfolio in Q4 2022, its #128 holding.
  • Monarch Partners Asset Management first reported a position in Organogenesis Holdings in Q2 2022 and has held it in 3 quarters since.
  • Monarch Partners Asset Management's Organogenesis Holdings position peaked at $1.47M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.